Skip to main content
Local News

Univ. of Washington Spinout Neoleukin Therapeutics Merging with New York City Startup

By July 27, 2023No Comments

After announcing in March that it was seeking “strategic alternatives” for its future, Seattle publicly-traded biotechnology company Neoleukin Therapeutics is now planning to merge with New York City-based Neurogene, a gene therapy startup.

In March, Neoleukin announced that it was discontinuing development of its computationally-designed immune therapy candidate and that CEO Jonathan Drachman was stepping down. The University of Washington spinout also slashed its workforce.